Skip to content

What happens if I stop taking methotrexate for psoriatic arthritis?

5 min read

Psoriatic arthritis (PsA) affects up to 0.25% of the U.S. population and is found in about 20% of people with psoriasis [1.6.1, 1.6.4]. If you're considering stopping your medication, it's crucial to understand: what happens if I stop taking methotrexate for psoriatic arthritis?

Quick Summary

Stopping methotrexate for psoriatic arthritis, especially abruptly, significantly increases the risk of a disease flare-up, which can cause returning joint pain, stiffness, and swelling. This must be done under strict medical supervision.

Key Points

  • Never Stop Abruptly: Halting methotrexate without a doctor's guidance is dangerous and can cause the disease to worsen [1.4.4].

  • High Risk of Flares: The most common result of stopping methotrexate is a flare-up of psoriatic arthritis symptoms like joint pain, swelling, and stiffness [1.2.2, 1.3.3].

  • Tapering is Safest: If discontinuation is necessary, doctors recommend a slow, gradual tapering of the dose to minimize flare risk [1.4.1, 1.4.2].

  • Reasons to Stop: Valid reasons for stopping, such as severe side effects or achieving sustained remission, must be evaluated by a rheumatologist [1.2.1, 1.2.3].

  • Risk of Joint Damage: Uncontrolled inflammation from stopping medication can lead to progressive and irreversible joint damage over time [1.9.1, 1.9.5].

  • Alternatives Are Available: If methotrexate is stopped, many other treatments like biologics or other DMARDs can effectively manage PsA [1.5.4].

  • Flares Can Be Managed: If a flare occurs after stopping, restarting methotrexate or another medication often helps regain disease control [1.2.1].

In This Article

The Role of Methotrexate in Managing Psoriatic Arthritis

Psoriatic arthritis (PsA) is a chronic, progressive inflammatory disease that affects the joints, skin, and sometimes other organs [1.9.3, 1.6.5]. If left untreated, it can lead to permanent joint damage and disability [1.9.1, 1.9.5]. Methotrexate is a cornerstone treatment for PsA. It belongs to a class of drugs called disease-modifying antirheumatic drugs (DMARDs) [1.5.4]. Its primary function is to suppress the overactive immune system that mistakenly attacks healthy joints and skin, thereby reducing inflammation, relieving symptoms like pain and swelling, and slowing the progression of the disease [1.5.4, 1.7.2]. Many patients rely on it as a long-term therapy to maintain remission or a state of low disease activity [1.3.1].

Warning: Do Not Stop Methotrexate Without Medical Supervision

It is critically important to never stop taking methotrexate or alter your dose without consulting your rheumatologist [1.2.1, 1.4.4]. Abruptly discontinuing the medication can lead to a significant risk of a disease flare and may cause your condition to worsen [1.2.2, 1.3.3]. Your feeling well is a sign the medication is working, not that it's no longer needed [1.2.1].

The Primary Risk: Disease Flare-Ups

The most significant and common consequence of stopping methotrexate is a recurrence of disease symptoms, known as a flare-up [1.2.2, 1.3.3]. While stopping the drug is not associated with a traditional withdrawal syndrome, the underlying disease can re-emerge once the medication's suppressive effects are gone [1.2.2].

A PsA flare can include a return or worsening of:

  • Joint pain, stiffness, and swelling [1.2.1]
  • Fatigue and fever [1.2.1]
  • Skin symptoms (psoriasis) [1.3.4]
  • Dactylitis ('sausage digits') and Enthesitis (inflammation where tendons attach to bone) [1.6.1]

Studies have shown that a significant percentage of patients who stop their DMARDs experience a severe flare-up [1.2.2]. The recurrence can happen within weeks to months after discontinuation [1.3.2]. One study noted that over 20% of those who stopped methotrexate for four weeks experienced a flare [1.2.2]. The risk of flare may be higher for those who were on larger doses of the medication [1.2.1].

Why and How to Stop Methotrexate Safely

A doctor may consider stopping or reducing methotrexate for several reasons:

  • Intolerable Side Effects: Common side effects include nausea, fatigue, mouth sores, and hair loss [1.7.1]. More severe but less common risks involve liver toxicity and reduced blood cell counts [1.7.2, 1.2.2]. In fact, adverse effects are the main reason for methotrexate withdrawal [1.2.3, 1.2.6].
  • Sustained Remission: If a patient has achieved long-term remission with minimal symptoms and low inflammation markers, a rheumatologist might suggest a change in treatment [1.2.1, 1.4.3].
  • Planning a Family: Methotrexate should not be used during pregnancy [1.7.3].

The decision to stop must be made with a healthcare provider. The recommended approach is a gradual dose reduction, known as tapering [1.4.2, 1.4.1]. Slowly tapering the dose is generally better than stopping abruptly, as it can reduce the risk and severity of a potential flare [1.2.2]. This allows you and your doctor to monitor for returning symptoms and, if necessary, re-start the medication or introduce an alternative treatment [1.4.1].

Comparison: Stopping vs. Continuing Methotrexate

Feature Stopping Methotrexate (Without Medical Guidance) Continuing Methotrexate (As Prescribed)
Disease Activity High risk of flare-ups and symptom return within weeks to months [1.3.2, 1.3.3]. Helps maintain remission or low disease activity [1.2.1].
Joint Health Increased risk of unchecked inflammation leading to progressive and permanent joint damage [1.9.1, 1.9.5]. Slows disease progression and helps prevent irreversible joint damage [1.5.4, 1.9.1].
Quality of Life Potential for decreased mobility, increased pain, and worsening of skin psoriasis [1.9.5]. Allows for better management of symptoms, improved function, and better quality of life [1.9.2].
Side Effects Avoidance of medication-related side effects [1.2.4]. Potential for side effects like nausea, fatigue, or, more rarely, liver issues that require monitoring [1.7.2].

Alternatives and Next Steps

If stopping methotrexate is necessary, it does not mean the end of treatment. Several other options are available to manage PsA, and your doctor will help create a new plan. This might happen before, during, or after tapering off methotrexate.

Alternative Medications

  • Other Conventional DMARDs: Leflunomide and sulfasalazine are other oral DMARDs that can be used [1.5.4, 1.5.5].
  • Biologic DMARDs: These newer drugs target specific parts of the immune system. Examples include TNF inhibitors (e.g., adalimumab, etanercept), IL-17 inhibitors (e.g., secukinumab), and IL-23 inhibitors (e.g., guselkumab) [1.5.3, 1.5.4]. Some research shows that patients taking a biologic may be able to stop methotrexate without a higher risk of flare-ups [1.2.1].
  • Targeted Synthetic DMARDs: This class includes JAK inhibitors like tofacitinib, which are oral medications that can reduce inflammation [1.5.4, 1.5.6].
  • Apremilast (Otezla): An oral medication that can be an option for mild to moderate PsA, especially for those who cannot or do not want to take DMARDs or biologics [1.5.4].

Managing Symptoms After Stopping

If a flare occurs after stopping methotrexate, the first step is to contact your rheumatologist. They may recommend restarting the medication, as many patients can regain control of their disease this way [1.2.1]. Alongside medical treatment, lifestyle strategies can help manage symptoms:

  • Anti-inflammatory Diet: Focus on fruits, vegetables, whole grains, and omega-3-rich fish like salmon. Limit processed foods, sugar, and alcohol [1.8.1, 1.8.5].
  • Gentle Exercise: Activities like swimming, walking, and yoga can maintain joint flexibility and muscle strength without adding stress [1.8.2].
  • Stress Management: Stress is a known trigger for flares. Techniques like meditation and getting enough sleep are beneficial [1.8.1, 1.8.3].
  • Heat and Cold Therapy: Heat can ease stiffness, while cold packs can reduce swelling and pain [1.8.4].

Conclusion: A Decision Guided by Your Doctor

Stopping methotrexate for psoriatic arthritis is a significant medical decision with the primary risk being a painful and potentially damaging disease flare. The feeling of wellness while on the drug is proof of its efficacy, not a sign that it's no longer needed. Any consideration of stopping or changing the dose must be initiated and supervised by a rheumatologist, who will likely recommend a slow tapering process [1.4.2]. If side effects are the issue, your doctor may have strategies to manage them or can transition you to one of the many other effective treatments available, ensuring your PsA remains controlled and protecting your joints from long-term damage [1.2.1, 1.9.1].


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any decisions about your treatment. For more information, you can visit the National Psoriasis Foundation.

Frequently Asked Questions

A flare-up can occur as early as two weeks after stopping methotrexate, though for most patients it happens within a few months. Some may not experience a recurrence for six months to a year [1.3.2].

No, there is no recognized withdrawal syndrome associated with stopping methotrexate itself. The symptoms experienced are a result of the underlying psoriatic arthritis flaring up, not a physical withdrawal from the drug [1.2.2].

Yes, in many cases, lowering the dose (tapering) is safer than stopping abruptly. This can sometimes control side effects while still managing the disease, and it reduces the risk of a severe flare [1.4.2]. Always discuss this with your doctor.

If you are in a state of sustained remission, your rheumatologist may discuss the option of reducing your dose or stopping the medication. This decision depends on factors like how long you've been in remission and your personal concerns about flaring [1.4.3].

If you stop taking methotrexate and the disease becomes active again, the uncontrolled inflammation can lead to progressive and permanent joint damage, which can cause stiffness, loss of motion, and disability [1.9.1, 1.9.5].

Yes, if you experience a flare after stopping, your doctor may suggest restarting your previous treatment plan. Studies show that a high percentage of patients are able to get their disease back under control after restarting methotrexate [1.2.1].

Alternatives include other conventional DMARDs (like leflunomide), biologic therapies that target specific parts of the immune system (like TNF inhibitors), and newer oral medications known as JAK inhibitors [1.5.4, 1.5.5, 1.5.6].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.